Joseph A. Ladapo, MD, PhD

Joseph A. Ladapo, MD, PhD


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

7 October 2014 in Annals of Internal Medicine
Verified
Journal Article
Closed access
JPJoseph A. Ladapo, MD, PhD
Joseph A. Ladapo, MD, PhD
SBSaul Blecker
Saul Blecker
PDPamela S. Douglas
Pamela S. Douglas
Cardiac stress testing with imaging has fueled debate about rising health care costs and radiation exposure. The authors analyzed repeated cross-sectional data and U.S. trends in cardiac stress tes... Background: Cardiac stress testing, particularly with imaging, has been the focus of debates about rising health care costs, inappropriate use, and patient safety in the context of radiation exposu...

10 June 2013 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
KDKarina Davidson
Karina Davidson
JBJ. Thomas Bigger
J. Thomas Bigger
MBMatthew M. Burg
Matthew M. Burg
RCRobert M. Carney
Robert M. Carney
WCWilliam F. Chaplin
William F. Chaplin
SYSiqin Ye
Siqin Ye
Depression will soon be the leading cause of years lived with disability worldwide1 and contributes even more to disability when comorbid with a chronic medical disorder.2,3 Every year, approximately 1.2 million Americans survive an acute coronary syndrome (ACS) event,4 and many have clinically significant and persistent depression.5,6 Patients with post-ACS depression have significantly more ambulatory medical appointments, emergency department visits, and higher health care costs than similar patients without depression.7,8 Post-ACS depression is also associated with a 150% increased risk of ACS recurrence9 and a 100% increase in the relative risk of all-cause mortality,2,10,11 and persistent depression after an ACS event is associated with an even higher morbidity and mortality risk.3,12 Reducing persistent post-ACS depression is therefore an important public health objective.

1 March 2012 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
PDF file
MRMatthew R. Reynolds
Matthew R. Reynolds
CGCandace L. Gunnarsson
Candace L. Gunnarsson
THTina D. Hunter
Tina D. Hunter
JPJoseph A. Ladapo, MD, PhD
Joseph A. Ladapo, MD, PhD
JMJamie L. March
Jamie L. March
SHSteven C. Hao
Steven C. Hao
Background—: Patients with atrial fibrillation (AF) face significant risks of stroke and heart failure. The objective of this study was to determine whether AF ablation reduces the long-term risk of stroke or heart failure compared with antiarrhythmic drug therapy. Methods and Results—: A coding algorithm was used to identify AF patients treated with catheter ablation (n=3194) or antiarrhythmic drugs without ablation (n=6028) between 2005 and 2009 using The MarketScan Research Database from Thomson Reuters From this sample, 801 pairs were propensity matched, based on 15 demographic and clinical characteristics and baseline medication use. Rates of stroke/transient ischemic attack (TIA) and heart failure hospitalizations for up to 3 years were examined. Patients treated with catheter ablation had a significantly lower rate of stroke or TIA (3.4% per year) than a group of patients with AF managed with antiarrhythmic drugs only (5.5% per year), with an unadjusted hazard ratio of 0.62 (95% CI, 0.44–0.86; P =0.005). The rates for heart failure hospitalization were 1.5% per year in the ablation group and 2.2% per year in the antiarrhythmic drug group, with an unadjusted hazard ratio of 0.69 (95% CI, 0.42–1.15; P =0.158). These results were minimally altered in Cox proportional hazards models, which further adjusted for potential confounders not well balanced by the propensity matching. Conclusions—: In a large propensity-matched community sample, AF ablation was associated with a reduced risk of stroke/TIA and no significant difference in heart failure hospitalizations compared with antiarrhythmic drug therapy. These findings require confirmation with randomized study designs.

1 September 2009 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
LWLori Warren
Lori Warren
JPJoseph A. Ladapo, MD, PhD
Joseph A. Ladapo, MD, PhD
BBBijan J. Borah
Bijan J. Borah
CGCandace L. Gunnarsson
Candace L. Gunnarsson

1 August 2008 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JPJoseph A. Ladapo, MD, PhD
Joseph A. Ladapo, MD, PhD
UHUdo Hoffmann
Udo Hoffmann
FBFabian Bamberg
Fabian Bamberg
JNJohn T. Nagurney
John T. Nagurney
DCDavid M. Cutler
David M. Cutler
GGG. Scott Gazelle
G. Scott Gazelle
OBJECTIVE. Patients at low risk for acute coronary syndrome (ACS) who present to the emergency department complaining of acute chest pain place a substantial economic burden on the U.S. health care system. Noninvasive 64-MDCT coronary angiography may facilitate their triage, and we evaluated its cost-effectiveness.MATERIALS AND METHODS. A microsimulation model was developed to compare costs and health effects of performing CT coronary angiography and either discharging, stress testing, or referring emergency department patients for invasive coronary angiography, depending on their severity of atherosclerosis, compared with a standard-of-care (SOC) algorithm that based management on biomarkers and stress tests alone.RESULTS. Using CT coronary angiography to triage 55-year-old men with acute chest pain increased emergency department and hospital costs by $110 and raised total health care costs by $200. In 55-year-old women, the technology was cost-saving; emergency department and hospital costs decreased by...